Aetion eBook Highlights the Impact of RWE in Successful Drug Approvals Ahead of FDA Framework
Aetion has published an eBook detailing how real world data (RWD) and real world evidence (RWE) can impact drug approvals [...]
Part 2 of Aetion’s ICPE Research Spotlight Highlights RWD in COVID-19 Research and Updated RWE Guidance
According to Aetion, key highlights of the August ICPE All Access Meeting hosted by the International Society for Pharmacology (ISPE) [...]
Quantitative Scientist Discusses Considerations for HTAs Using RWD
Dr. Philani Brian Mpofu discusses important considerations for health technology assessments (HTAs) using real world data (RWD) to understand drug [...]
Syneos Health Executive VP and Data Expert Discusses RWE and Aetion Collaboration
Executive Vice President of Real World Evidence (RWE) and Late Phase at Syneos Health Javier Jimenez discusses major industry trends [...]
Interview With RWE Expert on Expectations for FDA Framework
In a recent interview with The Evidence Base, real world evidence (RWE) expert Sreeram Ramagopalan shared his thoughts on the [...]
HEOR Expert Discusses RWE Career Paths and Emerging Healthcare Technologies
In a recent interview with The Evidence Base, Olivia Wu discussed her day-to-day work, the many career paths available to [...]
ICON Clinical Trial Experts Discuss the Intricacies of Rare Disease Studies
Two clinical trial experts at ICON shared their thoughts on clinical trial design, including important considerations and strategies for rare [...]
Rare Disease Meeting Highlights FDA’s RDCA-DAP Research Resource
A recent rare disease meeting brought together more than 400 attendees to introduce the Rare Disease Cures Accelerator-Data and Analytics [...]
Medical Data Expert Shares Thoughts on RWE and Healthcare Research Challenges
In a recent interview, Savana Founder and Chief Medical Officer Ignacio H. Medrano shared his thoughts on emerging healthcare research [...]
RWE Expert Discusses Ripple Effects of FDA Framework Throughout Pharma
In a recent interview, Roche’s Global Head of Real World Evidence (RWE) and Market Access Sreeram Ramagopalan shared his thoughts [...]
Evidence Partners Highlights the Time-Saving Power of AI in COVID-19 Data Extraction Case Study
In a recently described case study, a health agency was able to cut costs by using the DistillerSR artificial intelligence [...]
HTAs Fail to Address Healthcare Disparities in Value Assessments
Health and healthcare disparities continue to impact care and outcomes in diverse patient populations. Health technology assessments (HTAs) fail to [...]
CorEvitas and Inovalon Announce Expansion of Patient-Centered RWD Partnership
CorEvitas has announced an expanded collaboration with healthcare analytics organization Inovalon. The partnership will further research into chronic disease, including [...]
RWE Informs Decision-Making for Vaccines, Digital Therapeutics, and Medications
Real world evidence (RWE) is increasingly used in healthcare and pharma decision-making. A recent article explores its use in addressing [...]
NESTcc’s Active Surveillance Roadmap Open for Public Comments Until October
The National Evaluation System for health Technology (NESTcc) recently revealed its Active Surveillance Roadmap to collect secure de-identified real world data. [...]
HealthVerity Waterfall Strategy Uses Open and Closed De-Identified RWD to Understand COVID-19 and Emerging Variants
Real world data (RWD) has already yielded remarkable insight throughout the COVID-19 pandemic. One data management strategy uses both open [...]
NESTcc to Add Multi-Disciplinary Stakeholders to RWD Healthcare Group
The Medical Device Innovation Consortium (MDIC)’s National Evaluation System for health Technology Coordinating Center (NESTcc) issued a call for experts [...]
Harvard Researchers Provide Guidance for Reviewers of RWE Studies
A recent article, published in Clinical Pharmacology and Therapeutics, highlights common pitfalls facing reviewers more familiar with reviewing randomized controlled [...]
New Cytel Blog on Causal Inference and RWD in Decision Making
A new Cytel blog post discusses using real world data (RWD) to bypass phase IV clinical trials. In contrast to [...]
UNC Cancer Hospital Combines RWD and Patient-Centered Care to Identify Unvaccinated Patients
A team of healthcare professionals at the University of North Carolina’s NC Cancer Hospital used real world data (RWD) derived [...]
ICER Revises 2018 Hereditary Angioedema Report Using RWE, Recommends Up to 75% Price Reduction
Researchers at the Institute for Clinical and Economic Review (ICER), Aetion, and the University of Washington collaborated to determine how [...]
Brown University Biostatistician Discusses Intercurrent Events, RWE, and Estimands
Dr. Roee Gutman recently shared his thoughts on the state of real world evidence (RWE) as it relates to health [...]
Catherine Richards Takes On Role of Chief Data Officer and RWD Products Head at ConcertAI
Dr. Catherine Richards will take on the position of chief data officer and senior vice president of real world data [...]
The Rare Patient Voice and RWD Leader Clinakos Announce Partnership Intended to Improve Understanding of the Patient Experience
The Rare Patient Voice, an organization that recruits patients diagnosed with rare diseases, and real world data (RWD) company Clinakos [...]
Upcoming ISPOR Webinar on Successfully Incorporating External Controls Into Oncology RWE Studies
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will host a webinar on August 12th at 2:00 PM EDT on successfully [...]